NO20023606L - Kombinatorielle proteindomener - Google Patents

Kombinatorielle proteindomener Download PDF

Info

Publication number: NO20023606L
Authority: NO; Norway
Prior art keywords: accordance; protein; chimeric protein; chimeric; amino acid
Prior art date: 2000-02-03

Application number

NO20023606A

Other languages

English (en)

Norwegian (no)

Other versions

NO20023606D0 (no

Inventor

Lutz Riechmann

Greg Winter

Original Assignee

Domantis Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-03

Filing date

2002-07-30

Publication date

2002-10-02

2000-02-03 Priority claimed from GB0002492A external-priority patent/GB0002492D0/en

2000-07-03 Priority claimed from GB0016346A external-priority patent/GB0016346D0/en

2000-08-07 Priority claimed from GB0019362A external-priority patent/GB0019362D0/en

2002-07-30 Application filed by Domantis Ltd filed Critical Domantis Ltd

2002-07-30 Publication of NO20023606D0 publication Critical patent/NO20023606D0/no

2002-10-02 Publication of NO20023606L publication Critical patent/NO20023606L/no

Links

108020001580 protein domains Proteins 0.000 title claims description 78
108090000623 proteins and genes Proteins 0.000 claims description 277
102000004169 proteins and genes Human genes 0.000 claims description 192
102000037865 fusion proteins Human genes 0.000 claims description 186
108020001507 fusion proteins Proteins 0.000 claims description 186
125000003275 alpha amino acid group Chemical group 0.000 claims description 84
230000027455 binding Effects 0.000 claims description 72
108090000765 processed proteins & peptides Proteins 0.000 claims description 55
238000000034 method Methods 0.000 claims description 54
102000004196 processed proteins & peptides Human genes 0.000 claims description 50
150000007523 nucleic acids Chemical class 0.000 claims description 48
229920001184 polypeptide Polymers 0.000 claims description 47
102000039446 nucleic acids Human genes 0.000 claims description 44
108020004707 nucleic acids Proteins 0.000 claims description 44
150000001413 amino acids Chemical class 0.000 claims description 35
239000012634 fragment Substances 0.000 claims description 34
230000017854 proteolysis Effects 0.000 claims description 30
108091005804 Peptidases Proteins 0.000 claims description 23
108091026890 Coding region Proteins 0.000 claims description 20
239000002773 nucleotide Substances 0.000 claims description 19
125000003729 nucleotide group Chemical group 0.000 claims description 19
230000014509 gene expression Effects 0.000 claims description 17
230000035772 mutation Effects 0.000 claims description 17
230000015572 biosynthetic process Effects 0.000 claims description 15
108090000144 Human Proteins Proteins 0.000 claims description 14
102000003839 Human Proteins Human genes 0.000 claims description 14
230000004927 fusion Effects 0.000 claims description 14
238000003786 synthesis reaction Methods 0.000 claims description 13
108700026244 Open Reading Frames Proteins 0.000 claims description 11
238000004519 manufacturing process Methods 0.000 claims description 11
238000000338 in vitro Methods 0.000 claims description 10
239000003550 marker Substances 0.000 claims description 9
241000724791 Filamentous phage Species 0.000 claims description 8
241001515965 unidentified phage Species 0.000 claims description 8
101710132601 Capsid protein Proteins 0.000 claims description 6
101710094648 Coat protein Proteins 0.000 claims description 6
102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 6
101710125418 Major capsid protein Proteins 0.000 claims description 6
101710141454 Nucleoprotein Proteins 0.000 claims description 6
101710083689 Probable capsid protein Proteins 0.000 claims description 6
238000001727 in vivo Methods 0.000 claims description 6
238000006243 chemical reaction Methods 0.000 claims description 5
230000008878 coupling Effects 0.000 claims description 5
238000010168 coupling process Methods 0.000 claims description 5
238000005859 coupling reaction Methods 0.000 claims description 5
241000282412 Homo Species 0.000 claims description 4
108020004511 Recombinant DNA Proteins 0.000 claims description 4
230000002255 enzymatic effect Effects 0.000 claims description 4
238000013519 translation Methods 0.000 claims description 4
229960005486 vaccine Drugs 0.000 claims description 4
125000000539 amino acid group Chemical group 0.000 claims description 3
238000001212 derivatisation Methods 0.000 claims description 3
238000005516 engineering process Methods 0.000 claims description 3
230000005714 functional activity Effects 0.000 claims description 3
230000001225 therapeutic effect Effects 0.000 claims description 3
150000001720 carbohydrates Chemical class 0.000 claims description 2
150000002484 inorganic compounds Chemical class 0.000 claims description 2
229910010272 inorganic material Inorganic materials 0.000 claims description 2
150000003431 steroids Chemical class 0.000 claims description 2
150000008574 D-amino acids Chemical class 0.000 claims 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
239000013065 commercial product Substances 0.000 claims 2
150000002894 organic compounds Chemical class 0.000 claims 1
241000588724 Escherichia coli Species 0.000 description 26
108020004414 DNA Proteins 0.000 description 21
239000004365 Protease Substances 0.000 description 19
239000013612 plasmid Substances 0.000 description 19
101710183938 Barstar Proteins 0.000 description 18
239000013598 vector Substances 0.000 description 17
108010016529 Bacillus amyloliquefaciens ribonuclease Proteins 0.000 description 16
241000283973 Oryctolagus cuniculus Species 0.000 description 16
108090000631 Trypsin Proteins 0.000 description 16
102000004142 Trypsin Human genes 0.000 description 15
230000000694 effects Effects 0.000 description 15
230000002797 proteolythic effect Effects 0.000 description 15
239000012588 trypsin Substances 0.000 description 15
108090001109 Thermolysin Proteins 0.000 description 14
230000006870 function Effects 0.000 description 14
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 13
239000000243 solution Substances 0.000 description 13
238000002965 ELISA Methods 0.000 description 12
108091028043 Nucleic acid sequence Proteins 0.000 description 12
210000004027 cell Anatomy 0.000 description 12
239000003446 ligand Substances 0.000 description 12
108020004705 Codon Proteins 0.000 description 11
210000004899 c-terminal region Anatomy 0.000 description 11
108020005038 Terminator Codon Proteins 0.000 description 10
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
230000004048 modification Effects 0.000 description 9
238000012986 modification Methods 0.000 description 9
238000012216 screening Methods 0.000 description 9
230000028993 immune response Effects 0.000 description 8
241000276498 Pollachius virens Species 0.000 description 7
108010090804 Streptavidin Proteins 0.000 description 7
238000012217 deletion Methods 0.000 description 7
230000037430 deletion Effects 0.000 description 7
238000013461 design Methods 0.000 description 7
230000006872 improvement Effects 0.000 description 7
238000002955 isolation Methods 0.000 description 7
230000008018 melting Effects 0.000 description 7
238000002844 melting Methods 0.000 description 7
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
230000008707 rearrangement Effects 0.000 description 7
238000002255 vaccination Methods 0.000 description 7
238000005481 NMR spectroscopy Methods 0.000 description 6
108091034117 Oligonucleotide Proteins 0.000 description 6
238000012408 PCR amplification Methods 0.000 description 6
102000035195 Peptidases Human genes 0.000 description 6
150000001408 amides Chemical group 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
238000005215 recombination Methods 0.000 description 6
230000006798 recombination Effects 0.000 description 6
229920000936 Agarose Polymers 0.000 description 5
101150031366 P3 gene Proteins 0.000 description 5
241000700605 Viruses Species 0.000 description 5
239000011324 bead Substances 0.000 description 5
239000004202 carbamide Substances 0.000 description 5
238000003776 cleavage reaction Methods 0.000 description 5
230000001747 exhibiting effect Effects 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
230000003053 immunization Effects 0.000 description 5
238000002649 immunization Methods 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
230000003993 interaction Effects 0.000 description 5
238000002823 phage display Methods 0.000 description 5
102000005962 receptors Human genes 0.000 description 5
108020003175 receptors Proteins 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
241000283707 Capra Species 0.000 description 4
108090000317 Chymotrypsin Proteins 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
241000701959 Escherichia virus Lambda Species 0.000 description 4
108010001336 Horseradish Peroxidase Proteins 0.000 description 4
102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
239000002671 adjuvant Substances 0.000 description 4
238000000137 annealing Methods 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
239000000872 buffer Substances 0.000 description 4
229960002376 chymotrypsin Drugs 0.000 description 4
238000010276 construction Methods 0.000 description 4
210000000805 cytoplasm Anatomy 0.000 description 4
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 4
238000010828 elution Methods 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
239000000047 product Substances 0.000 description 4
230000007017 scission Effects 0.000 description 4
238000005406 washing Methods 0.000 description 4
241000702333 Enterobacteria phage G4 Species 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
230000004570 RNA-binding Effects 0.000 description 3
210000001744 T-lymphocyte Anatomy 0.000 description 3
125000001931 aliphatic group Chemical group 0.000 description 3
230000008901 benefit Effects 0.000 description 3
238000007413 biotinylation Methods 0.000 description 3
238000004422 calculation algorithm Methods 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000001142 circular dichroism spectrum Methods 0.000 description 3
238000009510 drug design Methods 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000003278 mimic effect Effects 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000000178 monomer Substances 0.000 description 3
238000002703 mutagenesis Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
239000011022 opal Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000007928 solubilization Effects 0.000 description 3
238000005063 solubilization Methods 0.000 description 3
238000004611 spectroscopical analysis Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
101710187001 DNA terminal protein Proteins 0.000 description 2
241000702374 Enterobacteria phage fd Species 0.000 description 2
108010067902 Peptide Library Proteins 0.000 description 2
102000009097 Phosphorylases Human genes 0.000 description 2
108010073135 Phosphorylases Proteins 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
101710174009 Suppressor of RNA silencing p3 Proteins 0.000 description 2
241000656145 Thyrsites atun Species 0.000 description 2
108020004566 Transfer RNA Proteins 0.000 description 2
239000002253 acid Substances 0.000 description 2
238000003556 assay Methods 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
230000006287 biotinylation Effects 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
239000012228 culture supernatant Substances 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
238000009826 distribution Methods 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical group NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
210000003630 histaminocyte Anatomy 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
230000004807 localization Effects 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
102000022744 oligopeptide binding proteins Human genes 0.000 description 2
108091013547 oligopeptide binding proteins Proteins 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
210000002729 polyribosome Anatomy 0.000 description 2
230000008569 process Effects 0.000 description 2
230000012846 protein folding Effects 0.000 description 2
238000000575 proteomic method Methods 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000002708 random mutagenesis Methods 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
210000004708 ribosome subunit Anatomy 0.000 description 2
102200006156 rs876658534 Human genes 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
108010051423 streptavidin-agarose Proteins 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000001629 suppression Effects 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000007704 transition Effects 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
108050003931 30S ribosomal proteins Proteins 0.000 description 1
WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 1
241000238876 Acari Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 description 1
101710192393 Attachment protein G3P Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
108090000565 Capsid Proteins Proteins 0.000 description 1
108010049152 Cold Shock Proteins and Peptides Proteins 0.000 description 1
101710090243 Cold shock protein CspB Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
101710179596 Gene 3 protein Proteins 0.000 description 1
PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
101001066878 Homo sapiens Polyribonucleotide nucleotidyltransferase 1, mitochondrial Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
125000002061 L-isoleucyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](C([H])([H])[H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
108091036060 Linker DNA Proteins 0.000 description 1
101710092121 Major cold shock protein Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
108010006519 Molecular Chaperones Proteins 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
238000012565 NMR experiment Methods 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
102000002681 Polyribonucleotide nucleotidyltransferase Human genes 0.000 description 1
241000350158 Prioria balsamifera Species 0.000 description 1
101710132457 Protein A1 Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
208000035415 Reinfection Diseases 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108700036684 S1 domains Proteins 0.000 description 1
102000044437 S1 domains Human genes 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
238000012896 Statistical algorithm Methods 0.000 description 1
108090000787 Subtilisin Proteins 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000003321 amplification Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
239000000427 antigen Substances 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
238000013459 approach Methods 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
238000003491 array Methods 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
238000013378 biophysical characterization Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
108091006004 biotinylated proteins Proteins 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
102220363249 c.40C>A Human genes 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000002983 circular dichroism Methods 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000003795 desorption Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000010432 diamond Substances 0.000 description 1
238000000113 differential scanning calorimetry Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000009088 enzymatic function Effects 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
210000003000 inclusion body Anatomy 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000009413 insulation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002372 labelling Methods 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
239000000155 melt Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000003471 mutagenic agent Substances 0.000 description 1
210000004897 n-terminal region Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
238000005457 optimization Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
101150040383 pel2 gene Proteins 0.000 description 1
101150050446 pelB gene Proteins 0.000 description 1
239000008188 pellet Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
108700010839 phage proteins Proteins 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
238000002818 protein evolution Methods 0.000 description 1
230000004853 protein function Effects 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
230000006432 protein unfolding Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
102220177887 rs369865672 Human genes 0.000 description 1
102220329197 rs776688705 Human genes 0.000 description 1
101150012310 rspA gene Proteins 0.000 description 1
238000013341 scale-up Methods 0.000 description 1
238000010187 selection method Methods 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
238000001890 transfection Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
108020005087 unfolded proteins Proteins 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
238000001363 water suppression through gradient tailored excitation Methods 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Physics & Mathematics (AREA)
Crystallography & Structural Chemistry (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Plant Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20023606A 2000-02-03 2002-07-30 Kombinatorielle proteindomener NO20023606L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0002492A GB0002492D0 (en)	2000-02-03	2000-02-03	Combinatorial protein domains
US18032600P	2000-02-04	2000-02-04
GB0016346A GB0016346D0 (en)	2000-07-03	2000-07-03	Combinatorial protein domains
GB0019362A GB0019362D0 (en)	2000-08-07	2000-08-07	Combinational protein Domains
PCT/GB2001/000445 WO2001057065A2 (fr)	2000-02-03	2001-02-02	Domaine de protéines combinatoire

Publications (2)

Publication Number	Publication Date
NO20023606D0 NO20023606D0 (no)	2002-07-30
NO20023606L true NO20023606L (no)	2002-10-02

Family

ID=27447768

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023606A NO20023606L (no)	2000-02-03	2002-07-30	Kombinatorielle proteindomener

Country Status (7)

Country	Link
EP (1)	EP1252319A2 (fr)
JP (1)	JP2003523742A (fr)
AU (1)	AU3040101A (fr)
CA (1)	CA2399809A1 (fr)
GB (1)	GB2375112A (fr)
NO (1)	NO20023606L (fr)
WO (1)	WO2001057065A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1627062A1 (fr)	2003-05-14	2006-02-22	Domantis Limited	Procede de recuperation de polypeptides qui se deplient de facon reversible a partir d'un repertoire de polypeptides
KR20100018040A (ko)	2007-06-06	2010-02-16	도만티스 리미티드	프로테아제 내성 폴리펩티드를 선택하는 방법
DE112008003232T5 (de)	2007-11-30	2011-02-24	Glaxo Group Limited, Greenford	Antigen-Bindungskonstrukte
EP2364326B1 (fr)	2008-12-05	2018-07-04	Glaxo Group Limited	Procédés de sélection de polypeptides résistants aux protéases
WO2010097385A1 (fr)	2009-02-24	2010-09-02	Glaxo Group Limited	Constructions de liaison d'antigène
US20110305694A1 (en)	2009-02-24	2011-12-15	Paul Andrew Hamblin	Multivalent and/or multispecific rankl-binding constructs
WO2010097386A1 (fr)	2009-02-24	2010-09-02	Glaxo Group Limited	Constructions de liaison d'antigène
EP2853542A1 (fr)	2010-11-24	2015-04-01	Glaxo Group Limited	Protéines multispécifique se liant à un antigène et ciblant HGF
MX2014001019A (es)	2011-07-27	2014-05-13	Glaxo Group Ltd	Dominios variables singulares anti-vgf fusionados con dominios de fc.
EP3561703B1 (fr) *	2018-04-25	2021-01-20	Bayer AG	Identification d'appariement de domaines variables des chaînes légères et lourdes d'anticorps
JPWO2023140360A1 (fr) *	2022-01-20	2023-07-27

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2715940B1 (fr) *	1994-02-10	1996-04-26	Pasteur Merieux Serums Vacc	Procédé de préparation d'une banque multicombinatoire de vecteurs d'expression de gènes d'anticorps, banque et systèmes d'expression d'anticorps "coliclonaux" obtenus.
WO1997032017A1 (fr) *	1996-02-26	1997-09-04	Morphosys Gesellschaft Für Proteinoptimierung Mbh	Nouvelle methode pour l'identification de sequences d'acides nucleiques codant pour deux (poly)peptides interactifs, ou plus
DK1078051T3 (da) *	1998-05-13	2008-04-07	Domantis Ltd	Fagvisningsselektionssystem til selektion af korrekt foldede proteiner
GB9929061D0 (en) *	1999-12-08	2000-02-02	Medical Res Council	Methods of producing novel enzymes

2001
- 2001-02-02 JP JP2001557896A patent/JP2003523742A/ja active Pending
- 2001-02-02 GB GB0217404A patent/GB2375112A/en not_active Withdrawn
- 2001-02-02 CA CA002399809A patent/CA2399809A1/fr not_active Abandoned
- 2001-02-02 WO PCT/GB2001/000445 patent/WO2001057065A2/fr not_active Application Discontinuation
- 2001-02-02 EP EP01902549A patent/EP1252319A2/fr not_active Withdrawn
- 2001-02-02 AU AU30401/01A patent/AU3040101A/en not_active Abandoned
2002
- 2002-07-30 NO NO20023606A patent/NO20023606L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2003523742A (ja)	2003-08-12
WO2001057065A3 (fr)	2002-01-31
AU3040101A (en)	2001-08-14
GB0217404D0 (en)	2002-09-04
GB2375112A (en)	2002-11-06
WO2001057065A2 (fr)	2001-08-09
CA2399809A1 (fr)	2001-08-09
NO20023606D0 (no)	2002-07-30
EP1252319A2 (fr)	2002-10-30

Legal Events

Date	Code	Title	Description
2004-12-20	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
US9422548B2 (en)	2016-08-23	OB-fold used as scaffold for engineering new specific binders
CA2710140C (fr)	2018-09-04	Banques de polypeptides presentant une structure predeterminee
AU2007218045B2 (en)	2011-11-10	Method of constructing and screening libraries of peptide structures
US20150275201A1 (en)	2015-10-01	Repeat protein from collection of repeat proteins comprising repeat modules
CA3106279A1 (fr)	2020-01-23	Conception de novo de commutateurs proteiques
WO2007139397A1 (fr)	2007-12-06	Domaines de type ob fold
JP2001527417A (ja)	2001-12-25	核酸結合タンパク質
KR20040018316A (ko)	2004-03-03	스캐폴드 구조의 ｃ-타입 렉틴 유사 도메인을 가지는단백질의 조합 라이브러리
NO20023606L (no)	2002-10-02	Kombinatorielle proteindomener
US9897611B2 (en)	2018-02-20	Molecule library constructed on the basis of backbone structure of microprotein
WO2006058226A2 (fr)	2006-06-01	Streptavidines dimeres modifiees et leurs utilisations
Johnsson et al.	1999	Phage display of combinatorial peptide and protein libraries and their applications in biology and chemistry
JP2004528802A (ja)	2004-09-24	Ｄｎａおよびタンパク質を結合する小型タンパク質
WO1992015702A1 (fr)	1992-09-17	Selection biologique de molecules utiles
Kay	1995	Biologically displayed random peptides as reagents in mapping protein-protein interactions
WO2002012277A2 (fr)	2002-02-14	Nouvelles proteines
US20030078192A1 (en)	2003-04-24	Combinatorial protein domains
KR20110003547A (ko)	2011-01-12	인위적인 단백질 스캐폴드
JP2003502022A (ja)	2003-01-21	自己会合性生体分子構造物
Ku	1995	A combinatorial approach towards molecular recognition
O'Neil	1998	Protein engineering by phage display
Parmeggiani	2008	Design of armadillo repeat protein scaffolds
Chin	2001	Design and evolution of functional miniature proteins
Dawson	1996	Deciphering the molecular basis of protein function through chemical synthesis